Cardiac Biomarker Soluble ST2 Shows Significant Clinical Value Over Natriuretic Peptide Markers In Monitoring Hospitalized Heart Failure Patients
Nov 27th 2008Drug InformationCardiovascular
Critical Diagnostics announced today the publication of a key research paper identifying the clinical value of the cardiac biomarker soluble ST2 (sST2) as a tool to monitor patients hospitalized for heart failure. The research paper, “Serial Sampling of ST2 Predicts 90-day Mortality Following Destabilized Heart Failure” was published in the current issue of Journal of Cardiac Failure .
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
